MedTrace Logo

Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia

NCT02986620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 388

Last updated 2022-01-04

No results posted yet for this study

Summary

This is a study where there are no interventions planned. Investigators will only collect data already in the patient's history and analyze it. Particularly, we are interested in molecular data from AML patients.

This means that patients will follow their regular diagnostic and clinical practice. The analyses will be conducted according to the routine diagnostic and clinical practice as well and no additional blood withdrawal will be performed.

Conditions

  • AML, Adult

Interventions

GENETIC

IDH mutation test performed at diagnosis or relapse until January 31st, 2019.

Observation of the test result.

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Giovanni Martinelli · Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna

  • Maria Teresa Voso · U.O.C. Ematologia Dipartimento di Medicina, Policlinico Tor Vergata of Rome

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2021-03-22
Completion
2021-03-22

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02986620 on ClinicalTrials.gov